Papers
1
Total Citations
4
H-Index
1
About
Dr. Sida Hao is a urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer, particularly through the analysis of postoperative prognostic markers. Drawing from a high-volume center in Southeast China, Dr. Hao’s most cited work investigates the risk factors for persistent prostate-specific antigen (PSA) levels after radical prostatectomy—a critical indicator of residual disease and potential recurrence. By identifying clinical and pathological predictors of incomplete PSA clearance, this study provides actionable insights for refining surgical technique and postoperative surveillance. While early in their career, with their leading paper accumulating 4 citations, Dr. Hao’s contributions address a pressing clinical gap: improving the precision of curative surgery for localized prostate cancer. Their work underscores a commitment to translating real-world surgical data into evidence-based guidelines, ultimately aiming to reduce biochemical recurrence and enhance long-term patient outcomes. As a rising voice in urologic oncology, Dr. Hao is poised to shape risk-stratification strategies that bridge surgical practice and personalized cancer care.
Research Focus
Key Achievements
Top Papers
- 1